An aqueous-based process to bioactivate poly(ε-caprolactone)/mesoporous bioglass composite surfaces by prebiotic chemistry-inspired polymer coatings for biomedical applications

Despite the wide use of aliphatic polyesters, such as poly(L-lactic acid) (PLLA) and poly(ε-caprolactone) (PCL), for many biomedical applications, these materials are limited due to their hydrophobic properties and lack of functional groups to bond with ligands to enhance the cell reorganization. Recently, a composite consisting of bioglass and PCL was demonstrated to enhance the mechanical strength and to improve the degradation rate. Although numerous approaches have been developed to improve the wettability of aliphatic polyesters to create a favorable interface with cells, only few surface modification methods can be independently applied to surfaces with different material. In this work, mesoporous bioglass (MBG) nanoparticles embedded in PCL films were modified by the polymerization of aminomalonitrile (AMN) with 3,4,5-trihydroxybenzaldehyde (THBA). The copolymer layer was further utilized as a mediator to conjugate chitosan and evaluate the antibacterial efficacy. Our results show that the hydrophilicity of the composite membranes significantly improved after treatment. In addition, after immersion in simulated body fluid (SBF) for 14 days, hydroxyapatite formation was only observed on the treated membranes. This result demonstrates that the surface treatment did not alter the MBG bioactivity. Moreover, the cell culture results reveal that the extension level of cells and expression of alkaline phosphatase activity (ALP) of osteoblast-like (MG63) cells were higher on treated composite films compared to untreated ones. The results imply that the treatment procedure can be simultaneously and homogeneously applied to the organic/inorganic composites. In addition, Staphylococcus aureus adhesion on AMN-co-THBA and chitosan/ AMN-co-THBA was significantly lower than untreated PCL. Moreover, the percentage of dead bacteria was highest on the chitosan/ AMN-co-THBA membranes. These results indicate that the AMN-co-THBA modification can be used in composite materials and complex constructs, and it provides a potential method to create versatile surface properties for biomedical applications.